Muhlenberg Regional Medical Center

Riverside Oral Surgery Acquires the Office of James McMenamin in Warren, NJ

Retrieved on: 
Tuesday, July 12, 2022
Extraction (chemistry), Acquisition, Oral and maxillofacial surgery, Oral cancer, Muhlenberg Regional Medical Center, County Route 503 (New Jersey), Jersey City Medical Center, Instagram, GLOBE, Breast implant, Oral, New Jersey Devils, Orthognathic surgery, Department, Board, Dentistry, TMJ

WARREN TOWNSHIP, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Riverside Oral Surgery , the Official Oral Surgeons of the NJ Devils, and the largest surgeon-owned and operated Oral and Maxillofacial Surgery practice in New Jersey, announces their acquisition ofthe office of Dr. James P. McMenamin, located inWarren, NJ.

Key Points: 
  • WARREN TOWNSHIP, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Riverside Oral Surgery , the Official Oral Surgeons of the NJ Devils, and the largest surgeon-owned and operated Oral and Maxillofacial Surgery practice in New Jersey, announces their acquisition ofthe office of Dr. James P. McMenamin, located inWarren, NJ.
  • Dr. James McMenamin is a Board CertifiedOral and Maxillofacial Surgeon who hasand will continue to servethe Warren community forover three decades.Dr.
  • McMenamin currently serves Jersey City Medical Centeras both Chief of the Department ofOral and Maxillofacial Surgery as well as Director of the Oral and Maxillofacial Surgery Academic Residency program.
  • Dr. McMenamin had previously served Muhlenberg Regional Medical Center, prior to its closingin 2008, for the better part of 18 years as both Chief of Oral and Maxillofacial Surgery and Director of the Dental Department.

Tevogen Bio Appoints Distinguished Clinician and Former Matheny President and CEO, Dr. Kendell R. Sprott, to Corporate Advisory Board

Retrieved on: 
Thursday, June 23, 2022
Research, Infectious Diseases, Neurology, Genetics, Stem Cells, Biotechnology, Pharmaceutical, Health, Science, Oncology, CRS, Child, Newark Beth Israel Medical Center, Â, Rutgers University, Central Waqf Council, Area Health Education Centers Program, City, Department, Neurology, Malignancy, Clinical trial, COVID-19, Rutgers School of Dental Medicine, HLA, Virus, Cytokine release syndrome, Board, Medicine, Patient, Faculty, CTL, Board of directors, Virology, CD8, City News, Terminology, Quality of life, Toxic shock syndrome, Multimedia, New Jersey Medical School, Golden Apple Award, Saint Barnabas Medical Center, Thomas Jefferson University Hospital, Muhlenberg Regional Medical Center, Forward-looking statement, Company, Cell, Bio, Degenerative disease, CEO, Disability in Canada, Morehouse College, Cancer, Pharmaceutical industry, Vaccine, Pediatrics

View the full release here: https://www.businesswire.com/news/home/20220623005876/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220623005876/en/
    Former Matheny President and CEO, Kendell R. Sprott, M.D., J.D.
  • joins Tevogen Bios Corporate Advisory Board.
  • His extensive, distinguished, and illustrious career speaks for itself, and I am honored to have him join Tevogens Corporate Advisory Board, said Tevogen CEO Ryan Saadi , M.D., M.P.H.
  • Tevogen Bio is driven by a team of distinguished scientists and highly experienced biopharmaceutical leaders who have successfully developed and commercialized multiple franchises.